Works matching IS 00070920 AND DT 2019 AND VI 120 AND IP 9


Results: 12
    1
    2
    3

    Sorafenib alone vs. sorafenib plus GEMOX as 1<sup>st</sup>-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial.

    Published in:
    British Journal of Cancer, 2019, v. 120, n. 9, p. 896, doi. 10.1038/s41416-019-0443-4
    By:
    • Assenat, Eric;
    • Pageaux, Georges-Philippe;
    • Thézenas, Simon;
    • Peron, Jean-Marie;
    • Bécouarn, Yves;
    • Seitz, Jean-François;
    • Merle, Philippe;
    • Blanc, Jean-Frédéric;
    • Bouché, Olivier;
    • Ramdani, Mohamed;
    • Poujol, Sylvain;
    • de Forges, Hélène;
    • Ychou, Marc;
    • Boige, Valérie
    Publication type:
    Article
    4
    6
    7
    9
    10

    Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.

    Published in:
    British Journal of Cancer, 2019, v. 120, n. 9, p. 922, doi. 10.1038/s41416-019-0427-4
    By:
    • Hänninen, Ulrika A.;
    • Wirta, Erkki-Ville;
    • Katainen, Riku;
    • Tanskanen, Tomas;
    • Hamberg, Jiri;
    • Taipale, Minna;
    • Böhm, Jan;
    • Renkonen-Sinisalo, Laura;
    • Lepistö, Anna;
    • Forsström, Linda M.;
    • Pitkänen, Esa;
    • Palin, Kimmo;
    • Seppälä, Toni T.;
    • Mäkinen, Netta;
    • Mecklin, Jukka-Pekka;
    • Aaltonen, Lauri A.
    Publication type:
    Article
    11

    Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes.

    Published in:
    British Journal of Cancer, 2019, v. 120, n. 9, p. 913, doi. 10.1038/s41416-019-0420-y
    By:
    • Bonnefoi, Hervé;
    • MacGrogan, Gaetan;
    • Poncet, Coralie;
    • Iggo, Richard;
    • Pommeret, Fanny;
    • Grellety, Thomas;
    • Larsimont, Denis;
    • Bécette, Véronique;
    • Kerdraon, Olivier;
    • Bibeau, Frédéric;
    • Ghnassia, Jean-Pierre;
    • Picquenot, Jean-Michel;
    • Thomas, Jeremy;
    • Tille, Jean-Christophe;
    • Slaets, Leen;
    • Bodmer, Alexandre;
    • Bergh, Jonas;
    • Cameron, David
    Publication type:
    Article
    12

    Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations.

    Published in:
    British Journal of Cancer, 2019, v. 120, n. 9, p. 941, doi. 10.1038/s41416-019-0434-5
    By:
    • Moon, Jai-Hee;
    • Hong, Seung-Woo;
    • Kim, Jeong Eun;
    • Shin, Jae-Sik;
    • Kim, Jin-Sun;
    • Jung, Soo-A;
    • Ha, Seung Hee;
    • Lee, Seul;
    • Kim, Joseph;
    • Lee, Dae Hee;
    • Park, Yoon Sun;
    • Kim, Dong Min;
    • Park, Sang-Soo;
    • Hong, Jun Ki;
    • Kim, Do Yeon;
    • Kim, Eun Ho;
    • Jung, Joonyee;
    • Kim, Mi Jin;
    • Kim, Seung-Mi;
    • Deming, Dustin A.
    Publication type:
    Article